Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
2018 Third quarter results announcement
On Wednesday 31 October we will announce our third quarter results for the period ended 30 September 2018.
Following the announcement there will be a webcast, hosted by Emma Walmsley, CEO; Simon Dingemans, CFO; Luke Miels, President, Global Pharmaceuticals; and David Redfern, Chief Strategy Officer at 14:30 GMT, 10:30 EDT.
Latest information
Latest press releases
- ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV
- GSK updates policy for working with healthcare professionals
- Positive results from Harmony Outcomes study of albiglutide published in The Lancet